Cascades (TSE:CAS – Get Free Report) had its price target upped by equities researchers at CIBC from C$12.00 to C$13.00 in a research note issued on Wednesday,BayStreet.CA reports. CIBC’s target price indicates a potential upside of 5.18% from the company’s current price.
Other equities research analysts also recently issued reports about the stock. TD Securities boosted their target price on shares of Cascades from C$12.00 to C$14.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Royal Bank of Canada increased their price target on Cascades from C$12.00 to C$13.00 and gave the stock a “sector perform” rating in a research note on Friday, December 20th. Five equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of C$12.50.
Read Our Latest Stock Analysis on CAS
Cascades Trading Up 3.0 %
Insider Buying and Selling at Cascades
In related news, Senior Officer Luc Langevin sold 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of C$11.30, for a total transaction of C$33,900.00. Company insiders own 23.78% of the company’s stock.
About Cascades
Cascades Inc produces, converts, and markets packaging and tissue products in Canada and the United States. The company operates through three segments: Containerboard, Specialty Products, and Tissue Papers. It offers various packaging solutions and tissue products comprised of recycled fibers; tissue papers, comprising parent rolls of virgin and recycled fibres; specialty products, including uncoated recycled boxboards; and containerboards.
See Also
- Five stocks we like better than Cascades
- Options Trading – Understanding Strike Price
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
- 3 Warren Buffett Stocks to Buy Now
- What Goldman Sachs’ Quarterly Results Reveal About the Economy
- How to Invest in Biotech Stocks
- 3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
Receive News & Ratings for Cascades Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cascades and related companies with MarketBeat.com's FREE daily email newsletter.